CASE REPORT

Uterine cervix mixed adenoneuroendocrine carcinoma: case report of a rare, high grade and aggressive tumor

I Gusti Ayu Sri Mahendra Dewi

I Gusti Ayu Sri Mahendra Dewi
Department of Pathology Anatomy, Faculty of Medicine, Universitas Udayana/Sanglah General Hospital Denpasar-Bali. Email: [email protected]
Online First: December 01, 2020 | Cite this Article
Dewi, I. 2020. Uterine cervix mixed adenoneuroendocrine carcinoma: case report of a rare, high grade and aggressive tumor. Bali Medical Journal 9(3): 587-590. DOI:10.15562/bmj.v9i3.1940


Introduction: Neuroendocrine carcinoma of the uterine cervix is a rare type of cancer in the female reproductive system, accounting for only about 1% of all malignancies in the uterine cervix. Mixed Adenoneuroendocrine Carcinoma (MANEC) is a combination of neuroendocrine components and non-neuroendocrine components, with each component contribute >30% of the tumor cells. This rare type of tumor is aggressive, high recurrence rates, and early distant metastases.

Case description: A 37-year-old female patient referred for evaluation after a previous finding of a cervix mass and a clinical diagnosis of cervical carcinoma IB2. Ultrasonography examination concluded a cervical mass, suspicious of malignancy. On macroscopic examination, it was found white-grey colored, huddle, and brittle mass filled the entire cervix with a size of 5x4 and 5x1 cm. Routine histopathological examination shows neoplastic cells forming a trabecular pattern, organoid, part with rosette formation, infiltrative between the connective tissue and a large area of necrosis. These cells conform to a uniform morphology, small oval to round nucleus, partially composed of molding, narrow cytoplasm, salt and pepper chromatin, and mitotic figure > 25/10 HPF. At some other focus, neoplastic cells appear cribriform, solid, and tubular, with a round to oval hyperchromatic nuclei, increased N/C ratio, severe nuclear pleomorphism, eosinophilic cytoplasm, mitotic figure 5/10 HPF. The metastatic cell was found in four right pelvic lymph nodes, and five left pelvic lymph nodes. Immunohistochemistry examination of chromogranin-A and CEA shows positive, focal distribution on tumor cells cytoplasms. Synaptophysin shows positive, diffuse distribution on tumors cell cytoplasm. Ki-67 was positive in 90% malignant cell nuclei.

Conclusion: The result of clinical, radiological, routine histopathology, and immunohistochemical examinations support the pathological diagnosis of MANEC.

References

Goldblum J, Lamps L, McKenney J, Myers J. Neuroendocrine Carcinoma. In: Rosai J, editor. Rosai and Ackerman’s Surgical Pathology. 7th ed. Philadelphia: Elsevier; 2018. p. 1280–3.

Shimojo N, Hirokawa Y, Kanayama K, Yoneda M, Hashizume R, Hayashi A, et al. Cytological features of adenocarcinoma admixed with small cell neuroendocrine carcinoma of the uterine cervix. Cytojournal. 2017;14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28603541/

Colgan T, Hirschowitz, Kim I, McCluggage W. Neuroendocrine tumours. In: Kurman J, Carcangiu M, Herrington C, Young R, editors. WHO Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon: IARC; 2014. p. 197–8.

Volante M, Birocco N, Gatti G, Duregon E, Lorizzo K, Fazio N, et al. Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. Hum Pathol. 2014;45(4):665–73. Available from: http://dx.doi.org/10.1016/j.humpath.2013.03.016

Ohike N, Adsay N, La R, Volante M, Zamboni G. Mixed neuroendocrine – non neuroendocrine neoplasms. In: Lloyd R, OSamura R, Kloppel, Rosai J, editors. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: IARC; 2017. p. 238–9.

Düzköylü Y, Aras O, Bostancı EB, Keklik Temuçin T, Ulaş M. Mixed Adeno-Neuroendocrine Carcinoma; Case Series of Ten Patients with Review of the Literature. Balkan Med J. 2018/03/19. 2018;35(3):263–7. Available from: https://pubmed.ncbi.nlm.nih.gov/29551754

Gurzu S, Kadar Z, Bara T, Bara Jr T, Tamasi A, Azamfirei L, et al. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases. World J Gastroenterol. 2015;21(4):1329–33. Available from: https://pubmed.ncbi.nlm.nih.gov/25632209

Sitthinamsuwan P, Angkathunyakul N, Chuangsuwanich T, Inthasorn P. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study. J Med Assoc Thail. 2013;96(1):83–90. Available from: http://www.jmatonline.com/index.php/jmat/article/view/2230

Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190–8. Available from: http://dx.doi.org/10.1016/j.ygyno.2011.04.011

Witkiewicz A, Wright T, Ferenczy A, Ronnet B, Kurman R. Carcinoma and Other Tumors of The Cervix. In: Kurman R, Ellenson L, Ronnet B, editors. Blaustein’s Pathology of the Female Genital Tract. 6th ed. New york: Springer; 2011. p. 290–3.

Gut P, Czarnywojtek A, Fischbach J, Bączyk M, Ziemnicka K, Wrotkowska E, et al. Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci. 2016/02/02. 2016;12(1):1–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26925113

Braga F, Ferraro S, Mozzi R, Dolci A, Panteghini M. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clin Biochem. 2013;46(1–2):148–51. Available from: http://dx.doi.org/10.1016/j.clinbiochem.2012.09.005

Oneda E, Liserre B, Bianchi D, Rota L, Savelli G, Zorzi F, et al. Diagnosis of Mixed Adenoneuroendocrine Carcinoma (MANEC) after Neoadjuvant Chemotherapy for Pancreatic and Gastric Adenocarcinoma: Two Case Reports and a Review of the Literature. Case Rep Oncol. 2019;12(2):434–42. Available from: https://pubmed.ncbi.nlm.nih.gov/31275134


Article Views      : 0
PDF Downloads : 0